CCR 20th Anniversary Commentary: Immune-Related Response Criteria—Capturing Clinical Activity in Immuno-Oncology

Axel Hoos; Jedd D. Wolchok; Rachel W. Humphrey; F. Stephen Hodi

doi:10.1158/1078-0432.CCR-14-3128

AACR Publications

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

AACR Publications

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

CCR 20th Anniversary Commentary

CCR 20^th Anniversary Commentary: Immune-Related Response Criteria—Capturing Clinical Activity in Immuno-Oncology

Axel Hoos, Jedd D. Wolchok, Rachel W. Humphrey and F. Stephen Hodi

Axel Hoos

1GlaxoSmithKline, Collegeville, Pennsylvania.

2Cancer Immunotherapy Consortium, New York, New York.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: Axel.x.Hoos@gsk.com

Jedd D. Wolchok

2Cancer Immunotherapy Consortium, New York, New York.

3Memorial Sloan Kettering Cancer Center, New York, New York.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rachel W. Humphrey

4CytomX, San Francisco, California.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

F. Stephen Hodi

5Dana-Farber Cancer Institute, Boston, Massachusetts.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: 10.1158/1078-0432.CCR-14-3128 Published November 2015

Article
Figures & Data
Info & Metrics
PDF

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: November 2015 to March 2021

	Abstract	Full-text HTML	PDF
Total	4087	3916	2776

Cited By

Article Information

Volume 21, Issue 22, pp. 4989-4991

DOI

https://doi.org/10.1158/1078-0432.CCR-14-3128

PubMed

26567357

Published By

American Association for Cancer Research

Print ISSN

1078-0432

Online ISSN

1557-3265

History

Received August 26, 2015
Accepted September 3, 2015
Published first November 12, 2015.

Author Information

Axel Hoos1,2,*,
Jedd D. Wolchok2,3,
Rachel W. Humphrey4, and
F. Stephen Hodi5

¹GlaxoSmithKline, Collegeville, Pennsylvania.
²Cancer Immunotherapy Consortium, New York, New York.
³Memorial Sloan Kettering Cancer Center, New York, New York.
⁴CytomX, San Francisco, California.
⁵Dana-Farber Cancer Institute, Boston, Massachusetts.

↵*Corresponding Author:
Axel Hoos, GlaxoSmithKline, Oncology R&D, 1250 South Collegeville Road, Collegeville, PA 19426. Phone: 610-427-3733; E-mail: Axel.x.Hoos{at}gsk.com

View Full Text

PreviousNext

November 2015
Volume 21, Issue 22

Table of Contents
Table of Contents (PDF)
About the Cover

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following CCR 20th Anniversary Commentary: Immune-Related Response Criteria—Capturing Clinical Activity in Immuno-Oncology

Message Subject (Your Name) has forwarded a page to you from Clinical Cancer Research

Message Body (Your Name) thought you would be interested in this article in Clinical Cancer Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

CCR 20^th Anniversary Commentary: Immune-Related Response Criteria—Capturing Clinical Activity in Immuno-Oncology